September 30, 2014—The Health Resources and Services Administration has awarded a five-year contract to Apexus to continue to run the 340B Prime Vendor Program. [ms-protect-content id=”2799″]
This is Apexus’ third consecutive five-year contract to run the program, which negotiates pharmaceutical pricing below the 340B ceiling price for its members and offers them other value-added services. Apexus announced that the contract had been awarded in a Sept. 29 news release.
“We are thrilled and proud for the opportunity to continue working with HRSA to strengthen this important program that helps so many families across the nation gain access to essential medications,” said Apexus President Chris Hatwig. “With our team’s unsurpassed knowledge of the 340B Program, our unique national distribution channels, and our highly regarded educational programs, we are able to deliver maximum value to 340B stakeholders through the promotion of program integrity, compliance, and optimization of the program.”
More than 18,000 340B providers participate in the PVP. [/ms-protect-content]